ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 230

Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study

Fabiola Atzeni1, Mariateresa Cirillo 2, Ignazio Francesco Masala 3, Piercarlo Sarzi-Puttini 4 and Alessandra Alciati 5, 1Rheumatology Unit, University of Messina, Messina, Italy., Messina, Italy, 2Rheumatology Unit, University of Messina, Italy, Messina, Italy, 3Orthopedic and Trauma Unit, Santissima Trinità Hospital, Cagliari, Italy, Cagliari, Italy, 4Rheumatology Unit, L.Sacco University Hopsital, Milan, Italy, Milan, Italy, 5Department of Clinical Neurosciences , Villa San Benedetto Menni, Hermanas Hospitalarias, FoRiPsi , Como , Italy and Humanitas Clinical and Research Center , Rozzano (Milan) , Italy., Milan, Italy

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: fibromyalgia and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim  was to evaluate the differences in depression-, anxiety- and stress-related events and trauma between patients with rheumatoid arthritis + Fibromyalgia [AR+FM] (SFM) and those with primary FM (PFM).

Methods: Study design: observational cross- sectional.  Patients were consecutively recruited. The inclusion criteria were an age of 18-70 years; a diagnosis of RA according to the  2010 ACR  criteria and FM according to the 1990 and 2016 ACR criteria. Lifetime diagnoses of major depression disorder (MDD), panic disorder (PD) and post-traumatic stress disorder (PTSD), three of the most frequently described psychiatric disorders among FM  patients were made by a senior psychiatrist using the Structured Clinical Interview for DSM-5 Axis I Disorders-Clinician Version and a single, cross-sectional assessment. Depressive symptoms were measured using the Zung Self-rating Depression Scale (ZSDS).  Childhood trauma was measured using the short form of the Childhood Trauma Questionnaire (CTQ).  Stressful events were assessed using the validated Italian version of Paykel’s Interview for Recent Life Events, a semi-structured interview investigating 64 life events. Pain was assessed using a VAS. The Italian version of the FIQ  was  used. Two-sided Fisher or T-test and multivariable logistic regression were performed.

Results: Seventy-seven patients were originally screened, but six were excluded.  The final analysis therefore involved 70 patients, all Caucasians: 30 with PFM and 40 with AR+FM. All patients with PFM and 38 (95%) of the 40 with AR+FM were treated for FM symptoms (antidepressants, pregabalin). The rates of lifetime MDD and PD were significantly higher in the PFM patients vs RA+FM (76.7% vs 40%, p =0.003), whereas there was no between-group difference in the rates of PTSD (50% in PFM vs 15% in SFM, p.003).  The PFM patients reported significantly higher levels of physical (p=0.020) and sexual abuse (p=0.011) and physical neglect (p< 0.001), whereas there was no between-group difference in the levels of emotional abuse (p=0.912) and  neglect (p=0.542); consistently, the proportion of sexually abused  (p=0.005 ) or phsically neglected patients was also higher in the PFM group (p=0.023). The rates of emotional neglect were high in both groups, without any significant difference between them. The vast majority  of AR+FM patients (90%) said that only event occurring in the year preceding the onset of FM was RA, whereas the PFM patients mainly reported non-physical events (36%, particularly the ending of a relationship, or working or financial problems) or no event at all (40%), (p< 0.001). Multivariable logistic regression used to identify the factors predicting association of PFM/AR+FM status, showed and association with lifetime major depression, life events preceding the development of FM, and BMI (p < 0.05 for all).

Conclusion:  

The study indicate that psychiatric co-morbidities and predisposing and precipitating environmental factors are different in patients with PFM from those in AR+FM patients, thus suggesting that the putative common pathogenetic condition of sensitisation may develop through different pathways. 


Disclosure: F. Atzeni, None; M. Cirillo, None; I. Masala, None; P. Sarzi-Puttini, None; A. Alciati, None.

To cite this abstract in AMA style:

Atzeni F, Cirillo M, Masala I, Sarzi-Puttini P, Alciati A. Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/patients-with-fibromyalgia-associated-with-rheumatoid-arthritis-and-patients-with-primary-fibromyalgia-differ-in-depression-anxiety-stress-related-disorders-and-events-a-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-fibromyalgia-associated-with-rheumatoid-arthritis-and-patients-with-primary-fibromyalgia-differ-in-depression-anxiety-stress-related-disorders-and-events-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology